| ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical ... - BioMedReports (subscription) |
|
|
BioMedReports (subscription) By PR Newswire: Biotechnology CCR2 inhibition in diabetic mice resulted in rapid and robust improvements of albuminuria, serum markers of renal function, and hyperglycemia. These data were highlighted today in a poster presentation titled "CCR2 ... ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical |